Subscribe: Market Wire - Pharmaceuticals and Biotech: Drugs
http://img.marketwire.com/rss/mwPBDR.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  announces  aug  august  cannabis  company  marketwired aug  marketwired august  marketwired  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Drugs

Marketwired - Drugs



Marketwired - Drugs



Last Build Date: Fri, 18 Aug 2017 11:34:02 EDT

Copyright: Copyright: (C) Marketwired
 



The Alliance for Regenerative Medicine Releases Q2 2017 Data Report, Highlighting Sector Trends and Metrics

Fri, 18 Aug 2017 11:01:25 EDT

WASHINGTON, DC--(Marketwired - Aug 18, 2017) - The Alliance for Regenerative Medicine (ARM) released today its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the second quarter and first half of 2017.




Ritter Pharmaceuticals Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP-G28 for Lactose Intolerance

Fri, 18 Aug 2017 09:30:00 EDT

Company has incorporated guidance from FDA on key elements of its Phase 3 program to support a New Drug Application (NDA) for RP-G28




Streetwise Reports Examines One Regenerative Medicine Firm to 'Keep a Close Eye On'

Fri, 18 Aug 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - August 18, 2017) - In an update on this company's clinical cell therapy programs targeting blood cancers and osteoarthritis in the knee, Gabrielle Zhou of Maxim Group describes progress that sets the stage for "value inflection."




Dewmar International BMC, Inc. (DEWM) Partners with Arkansas Company to Apply for Marijuana Cultivation and Dispensary Licenses

Fri, 18 Aug 2017 08:43:24 EDT

HOUSTON, TX--(Marketwired - Aug 18, 2017) - Dewmar International BMC, Inc. (the "Company") (OTC PINK: DEWM) today announced that it has partnered with a long-standing Arkansas company in a joint effort to see a cannabis cultivation and dispensary permit to be issued during fourth quarter 2017.




ViaDerma, Inc. Set to Begin Sales of its FDA Registered Topical Antibiotic in September with Initial Orders from Japan

Fri, 18 Aug 2017 08:00:00 EDT

Viaderma, Inc. announces Galaxy Solutions, Inc. as new sales representative for select Asia Pacific markets




HempAmericana selected as featured Investment for new Crowd Funding Portal, Minivest

Fri, 18 Aug 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Aug 18, 2017) - HempAmericana, Inc. (OTC: HMPQ) -- HempAmericana Inc. is excited to announce that the Company has been selected to be the first investment offered on a new and exciting Crowd Funding site designed exclusively for qualified Reg A offerings. 




The Role of Clinical Endpoint Committees in Medical Device Trials, a New Webinar Presented by Premier Research and Hosted by Xtalks

Fri, 18 Aug 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - August 18, 2017) - This webinar will discuss the value of clinical endpoint committees in medical device evaluation programs and explore the process of organizing, managing, and implementing a centralized adjudication process for standardizing study endpoints. The live broadcast takes place on Tuesday, September 12, 2017, with keynote speakers from Premier Research Joanne Emmett, Vice President of Medical Device & Diagnostics, and Janet Kube, Directorof Project Management.




Breaking News: CBIS/FSAO NAC Harvest Planning Session Held Yesterday Has Accelerated the Completion of the 60-acre Industrial Hemp Project Planted on the 250 acre CBIS/FSO NAC MBS001 Plot Currently Under Harvest

Thu, 17 Aug 2017 13:07:26 EDT

IRVINE, CA--(Marketwired - Aug 17, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC) is pleased to announce that after yesterday's planning session the group has accelerated the completion of the 60-acre project planted on the 250-acre CBIS/FSO NAC MBS001 plot currently underway. 




Medovex Corporation Names Charlie Farrahar Chief Financial Officer

Thu, 17 Aug 2017 12:50:00 EDT

ATLANTA, GA--(Marketwired - Aug 17, 2017) - Medovex Corp. (NASDAQ: MDVX) ("Medovex" or the "Company"), the developer of the DenerveXT System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to back pain, today reported it has named Charlie Farrahar as its Chief Financial Officer.




HealthDatix initiates pilot program with West Florida Health Network

Thu, 17 Aug 2017 11:48:19 EDT

SMITHTOWN, NY--(Marketwired - Aug 17, 2017) -  iGambit Inc. (OTCQB: IGMB) is pleased to announce that the company's wholly owned subsidiary, HealthDatix, Inc. has entered into a pilot program with West Florida Health Network (WFHN), which is a Community Integrated Network (CIN).




EnWave Corporation Hires Adelaide Capital Markets to Provide Investor Relations Services

Thu, 17 Aug 2017 09:00:00 EDT

VANCOUVER, BC--(Marketwired - August 17, 2017) - EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") today announced that it has hired Adelaide Capital Markets ("ACM") to provide investor relations and corporate development services for the Company.




Agritek Holdings, Inc. Announces Feature Interview As Public Cannabis Company Appearance On Fox Business Network August 20, 2017 On New To The Street

Thu, 17 Aug 2017 08:30:00 EDT

LOS ANGELES, CA--(Marketwired - Aug 17, 2017) - Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com, a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector, today announced that the Company's CEO B. Michael Friedman will be a featured guest speaker on Fox Business Network show "New To The Street."




Neptune annonce l'élection de ses administrateurs

Thu, 17 Aug 2017 08:00:00 EDT

LAVAL, QUÉBEC--(Marketwired - 17 août 2017) - Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce que les candidats désignés dans la circulaire de sollicitation de procurations datée du 13 juillet 2017 ont été élus à titre d'administrateurs de la Société. Les résultats détaillés du vote pour l'élection des administrateurs à l'assemblée annuelle des actionnaires tenue à Montréal le 15 août 2017 sont présentés ci-dessous.




Neptune Announces the Election of its Directors

Thu, 17 Aug 2017 08:00:00 EDT

LAVAL, QUEBEC--(Marketwired - Aug. 17, 2017) - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ:NEPT)(TSX:NEPT) announces that the nominees listed in its management proxy circular dated July 13, 2017 were elected as directors of the Corporation. The detailed results of the vote for the election of directors at its Annual Meeting of Shareholders held on August 15, 2017 in Montreal are set out below.




Golden Leaf Holdings to Hold Conference Call to Review Second Quarter 2017 Results

Thu, 17 Aug 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - August 17, 2017) - Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH) (CSE: GLH.CN) (CNSX: GLH) (OTCQB: GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it will report its financial results for the quarter ended June 30, 2017 on Tuesday, August 29, 2017, after market-close. Golden Leaf's management, led by Mr. William Simpson, Chief Executive Officer, will also hold a conference call to review the results at 4:30 PM ET on Tuesday, August 29, 2017.




HempLife Today Announces its new Website will be live by 5PM EDT on Friday, 8.18.2017

Thu, 17 Aug 2017 07:00:00 EDT

DENVER, CO--(Marketwired - Aug 17, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU), through its subsidiary HempLife TodayT, an innovative and growing Company offering the finest CBD (Cannabidiol) products derived from Hemp, is announcing that its new Website will be live by 5PM eastern time on Friday, 8.18.2017.




Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM

Wed, 16 Aug 2017 23:52:45 EDT

MONTRÉAL, QUÉBEC--(Marketwired - Aug. 16, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announced that the following individuals were elected as directors of Acasti Pharma Inc. ("Acasti" or the "Corporation") at its Annual and Special Meeting of Shareholders, held in Montreal, Canada on August 15, 2017 (the "AGM"): Janelle D'Alvise, Jean-Marie (John) Canan, Roderick N. Carter, Richard P. Schottenfeld and Katherine Crewe. Immediately prior to the AGM, Pierre Fitzgibbon and James S. Hamilton, who had been candidates for election to the Board and listed in the management proxy circular dated July 13, 2017, withdrew their candidacies for election to the Board. Mr. Fitzgibbon's withdrawal followed his resignation from the board of directors of Neptune Technology & Bioressources Inc. ("Neptune"). At the AGM, Neptune nominated Richard P. Schottenfeld and Katherine Crewe in their place. The detailed results of the vote for the election of directors are set out below:




Patients Are Not the #1 Target for Social Media & Other Digital Marketing Strategies, New Study Finds

Wed, 16 Aug 2017 17:42:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - August 16, 2017) - A new study of pharmaceutical marketing teams found that the primary digital strategy priority is to educate and communicate with physicians, making communication with patients across digital platforms a secondary priority.




Genome BC: Cannabis traits unlocked for better regulation

Wed, 16 Aug 2017 15:29:33 EDT

VANCOUVER, BC--(Marketwired - August 16, 2017) - Medical cannabis production is one of the fastest growing agri-biotech industries in BC, a province which is home to over 20% of Canada's licensed producers of medical cannabis. The federal Cannabis Act, which is currently before parliament, will legalize the non-medical use of cannabis and further expand cannabis production and distribution into a regulated, multibillion-dollar industry. However, a major issue for the industry is access to well-defined cannabis varieties, with supporting scientific information on their select traits.




Aequus Receives Approval for Short Form Base Shelf Prospectus to Raise up to C$20,000,000

Wed, 16 Aug 2017 14:29:42 EDT

VANCOUVER, BC--(Marketwired - August 16, 2017) -




Avadim Technologies Named to the Inc. 500 List of Fastest-Growing Private Companies in America for the Second Consecutive Year

Wed, 16 Aug 2017 13:42:42 EDT

Avadim Listed as the 13th Fastest Growing Company in U.S. Health Sector and 2nd Overall in North Carolina; Avadim Ranks No. 162 on the 2017 Inc. 500 List with Three-Year Sales Growth of 2,538%




Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses

Wed, 16 Aug 2017 10:34:37 EDT

TORONTO, ON--(Marketwired - Aug 16, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), pursuant to its previously announced closing agreement with Canadian based -- Alliance Group -- Easton has advanced $575,000 towards its acquired interest in 45 acres of a 135-acre fully owned parcel of land for the cultivation, production and sale of medical / recreational marijuana to the cannabis industry and towards other revenue producing businesses.




MediXall Group, Inc. Provider Network Is Now Over 3,000 Members

Wed, 16 Aug 2017 10:08:23 EDT

MediXall Group is growing Provider Network -- preparing to offer a full suite of unique medical financing solutions to Network Members




Cannabis Science and Free Spirit Organics Native American Corporation (FSO NAC) Begin Harvesting Approximately 60 Acres of its 250-Acre Industrial Hemp Project on San Joaquin Sovereign Tribal Fee Land MBS, California

Wed, 16 Aug 2017 09:16:58 EDT

IRVINE, CA--(Marketwired - Aug 16, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC), announce the initial harvesting of approximately 60 acres of industrial hemp on San Joaquin Sovereign Tribal Fee land MBS, California. The 2017 CBIS/FSO NAC MBS001 harvesting is a two-phase project, the first phase of the harvesting will be approximately 15-acres that is underway now, it is expected to be completed by the end of this month. Phase two will be the remaining 45 acres and is expected to be completed by the end of September 2017.




First Harvest Launches Ufly420 for On-Demand Legal Cannabis Delivery

Wed, 16 Aug 2017 08:30:00 EDT

Enabling Connectivity Technology




Sipp Industries Signs Letter of Intent to Acquire Minority Stake in Wanderport Corporation, Enhancing Product Selection

Wed, 16 Aug 2017 08:30:00 EDT

Sipp Industries Diversifies Specialty Hemp Beverage Line with the Addition of Sapa's Premium Coffee Blends to its Portfolio of Top Quality Hemp Beverages




420JobSearch.com and ZipRecruiter.com Announce Partnership, Broadening Jobs Offered

Wed, 16 Aug 2017 08:00:00 EDT

HENDERSON, NV--(Marketwired - Aug 16, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis and vape markets with innovative products, technologies, and services is pleased to announce a partnership between its Job Search Portal (420JobSearch.com) and ZipRecruiter.com420jobsearch.com recently entered into an agreement with ziprecruiter.com to enable both companies to broaden the scope of jobs available to job seekers. 




LiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index

Wed, 16 Aug 2017 08:00:00 EDT

ANAHEIM, CA--(Marketwired - Aug 16, 2017) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, is pleased to announce that Stock Watch Index has initiated equity analyst coverage on LVVV.




Tetra Bio-Pharma Announces Approval to List on the TSX Venture Exchange

Wed, 16 Aug 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - Aug. 16, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that its common shares have been approved for trading on the TSX Venture Exchange and that it has applied for voluntary delisting of its common shares from the Canadian Securities Exchange (CSE). Tetra's shares will commence trading on the TSX Venture on the opening of markets on Wednesday, August 16, 2017, under the symbol "TBP".




Maricann Group Inc. Enters Into Letter of Intent

Wed, 16 Aug 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Aug. 16, 2017) - Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI) ("Maricann" or the "Company") and a national provider that services pharmacies across Canada (the "Counterparty"), have agreed to a primary collaborative partnership through a joint initiative to create a pharmacy services program that enables pharmacists to counsel and appropriately educate patients in relation to medicinal cannabis.




NetworkNewsWire Announces Publication Discussing the Companies Ready to Strike on the Canadian Legal Marijuana Industry

Wed, 16 Aug 2017 07:30:00 EDT

NEW YORK, NY--(Marketwired - Aug 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VENTURE: ABCN) (OTCQB: ABCCF), a client of NNW that is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis.




Moleculin Acquires Active Drug Compound for the Treatment of Brain Cancer

Wed, 16 Aug 2017 07:30:00 EDT

HOUSTON, TX--(Marketwired - August 16, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center, today announced it has acquired WP1122 active drug compound it plans to study for the treatment of brain tumors.




Overcome Pharma Data Challenges to Improve Outcomes and Operations: Lessons Learned from Other Industries, New Webinar Hosted by Xtalks

Wed, 16 Aug 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - August 16, 2017) - In a live session on Friday, September 8, 2017, industry expert Gary Palgon, Vice President of Healthcare and Life Sciences Solutions at Liaison Technologies will examine what the future holds for the healthcare and pharma ecosystems making the digital transformation, leveraging big data - including new and existing data sources - and using technologies to enhance clinical and operations processes.




Why Making Every Product Truly Unique is the Key to Modern Brand Protection

Wed, 16 Aug 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - August 16, 2017) - In this live webinar, Jim Sinisgalli, Director of Product Management and Brand Protection at Systech will outline their ability to create trusted uniqueness in every product, and how this idea is central to a modern approach to brand protection.




Solvents, Polymers & Cyclones -- Bioavailability Enhancement through Spray Dried Dispersions

Wed, 16 Aug 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - August 16, 2017) - In an Xtalks webinar scheduled for Thursday, September 7, 2017 at 11am EDT (4pm BSK/UK), industry experts Stephie Lee, Associate Scientist at Catalent and Eric Gorman, Research Scientist II at Gilead Sciences, will introduce key spray dried dispersion development considerations allowing for identification of a stable prototype that will enhance and sustain in-vivo drug solubility. The discussion will include spray dried dispersion formulation development and early phase considerations for finished dose development.




Corix Bioscience, Inc. Signs Major Sales Agreement for up to 22,000 Pounds of Hemp per Month

Wed, 16 Aug 2017 06:00:00 EDT

PHOENIX, AZ--(Marketwired - Aug 16, 2017) - Corix Bioscience Inc. (OTCQB: CXBS), a next generation tissue cell culture to pharmaceutical grade cannabinoid oil (CBD) manufacturer, announced today that it has signed an agreement with Positively Green Organics LLC. for the resale of up to 22,000 pounds of industrial hemp per month.




Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

Tue, 15 Aug 2017 16:01:00 EDT

BERKELEY, CA--(Marketwired - August 15, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the completion of an underwritten public offering of 5,750,000 shares of its common stock, including 750,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters. All of the shares were offered by Dynavax at a price to the public of $15.00 per share. The net proceeds to Dynavax from this offering were approximately $80.8 million, after deducting the underwriting discount and other estimated offering expenses payable by Dynavax. Dynavax anticipates using the net proceeds from the proposed offering to fund activities associated with preparing for the anticipated U.S. commercial launch of HEPLISAV-BT [Hepatitis B Vaccine (Recombinant), Adjuvanted], should HEPLISAV-B gain approval by the Food and Drug Administration. In addition, net proceeds from the offering will support continuing the clinical development of its lead investigational cancer immunotherapeutic product candidates, SD-101 and DV281, continuing research and development activities, and for other general corporate purposes, including working capital.




/NOTICE TO DISREGARD - CleanSlate Centers

Tue, 15 Aug 2017 14:01:22 EDT

NORTHAMPTON, MA--(Marketwired - August 15, 2017) - We are advised by CleanSlate Centers that journalists and other readers should disregard the news release, "National Opioid Addiction Treatment Leader Partners with Indiana University Health Plans to Expand Access to Members", issued July 28, 2017, over Marketwired.




Cosmos Holdings, Inc. Announces Second Quarter 2017 Results

Tue, 15 Aug 2017 10:19:44 EDT

Revenue Improved 539% and Gross Profit Improved 487% compared to the three months ended June 30, 2016




UnityPoint Health Achieves Early Success with LogicStream Health Clinical Process Improvement Solutions

Tue, 15 Aug 2017 09:00:00 EDT

MINNEAPOLIS, MN--(Marketwired - Aug 15, 2017) - LogicStream Health announced today that UnityPoint Health® is already realizing the impact of its Clinical Process Improvement solutions on core initiatives, less than three months after implementation. The West Des Moines, Iowa-based health system is leveraging LogicStream to optimize its electronic health record (EHR) and understand its current EHR build.




Freedom Leaf, Inc. and WallStreet Research LLC Joint Venture To Become the Go-To Resource For Public Companies in the Marijuana/Hemp Sector: To Debut At InvestorHub Event MJAC2017 In Los Angeles September 1st & 2nd

Tue, 15 Aug 2017 09:00:00 EDT

Join (OTCQB: FRLF) & WallStreet Research at our Booth in Los Angeles' at the Premium Investment Cannabis Event MJAC2017: Come chat with us




Zynerba Failure Highlights the Need for Expertise, Broader Portfolios -- SECFilings.com

Tue, 15 Aug 2017 09:00:00 EDT

REDONDO BEACH, CA--(Marketwired - Aug 15, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc.'s. (OTCQB: AXIM) clinical progress and broad portfolio in light of Zynerba's recent Phase II cannabidiol (CBD) gel patch failure.




CV Sciences, Inc. Highlights Recent Research Showing Cannabidiol May Reduce Relapses in Smokeless Tobacco Addiction

Tue, 15 Aug 2017 08:45:00 EDT

LAS VEGAS, NV--(Marketwired - August 15, 2017) - CV Sciences, Inc. (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we") highlighted a recent study conducted at Federal University of Prana and Santa Catarina in Brazil which reports that preclinical and clinical studies suggested that cannabidiol (CBD) may help prevent drug addiction relapse. The research cites the effects of CBD drugs on the aversive and rewarding drug-associated memory extinction and reconsolidation, inhibiting the CB1 receptor to suppress reinstatement of drug rewarding memories.




NuLife Announces Pre-Clinical Trial of NuLife Technique

Tue, 15 Aug 2017 08:30:00 EDT

NEWPORT BEACH, CA--(Marketwired - August 15, 2017) - NuLife Sciences (OTCQB: NULF) through the company's wholly-owned subsidiary, NuLife BioMed, Inc., today announced that it is initiating a pre-clinical trial on the NuLife Technique, a means to potentially eliminate the need for organ or tissue matching between donor and recipient in organ transplants and the necessity for anti-rejection drugs after surgery.




American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In California

Tue, 15 Aug 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Aug 15, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) ("ACC"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured a client in the state of California. This client seeks to acquire a license that will permit them to dispense medical cannabis to patients. ACC has been contracted to complete operational planning activities, to provide conceptual design work for a retail dispensary location, to assist with 2017 city permitting, and to help with 2018 state application completion. Upon the client being awarded a city permit, ACC will be further retained in the dispensary deployment process where the consulting firm will provide facility staffing solutions, a customized set of operational workflow procedures, and remote operational monitoring support. ACC expects to leverage this contract to secure additional revenues through long-term consulting agreements and future sales of ancillary products, as this client is looking to seek licensure for the California recreational/adult-use cannabis program in the near future.




Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection

Tue, 15 Aug 2017 08:30:00 EDT

ATLANTA, GA and BOTHELL, WA--(Marketwired - Aug 15, 2017) - Cocrystal Pharma, Inc. (OTCQB: COCP), a clinical stage biopharmaceutical company focused on developing innovative antiviral therapeutics, today announced the successful completion and positive data from the Phase 1a/1b study for its lead broad spectrum compound, CC-31244, in healthy volunteers and in hepatitis C virus (HCV)-infected individuals. CC-31244 is a broad-spectrum, potent NS5B non-nucleoside inhibitor (NNI) of HCV replication with a high barrier to resistance.




Agritek Holdings, Inc. Announces Timely Filing Of Second Quarter Financial Results For 2017 And Provides Shareholder Update

Tue, 15 Aug 2017 08:30:00 EDT

LOS ANGELES, CA--(Marketwired - Aug 15, 2017) - Agritek Holdings, Inc. (OTCQB: AGTK), www.AgritekHoldings.com, a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector, today announced the timely filing of the Company's second quarter financial results for 2017. The filings may be viewed at www.AgritekHoldings.com under the investors section or the following link:




REPEAT - Cannabis Wheaton Announces Appointment of New Advisory Board Member

Tue, 15 Aug 2017 07:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 15, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE:CBW) ("Cannabis Wheaton" or "CW") is pleased to announce the appointment of Elfi Daniel-Ivad to the Advisory Board of Cannabis Wheaton.




Rennova Health Reports Second Quarter 2017 Financial Results

Tue, 15 Aug 2017 07:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - August 15, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company") reports financial results for the three and six months ended June 30, 2017 and provides a business update.




GrowCo Drives Two Rivers Water & Farming to Operational Net Income

Tue, 15 Aug 2017 07:00:00 EDT

Focus on Marijuana Infrastructure and Water Development Propels Growth




Revive Therapeutics Appoints Dr. Ram Subramanian, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases

Tue, 15 Aug 2017 07:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Aug. 15, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that Dr. Ram Subramanian, M.D., will join the Company as a Scientific Advisor for cannabinoid-based therapeutics targeting liver diseases.




Akers Biosciences Announces Q2 2017 Earnings

Tue, 15 Aug 2017 07:00:00 EDT

Total Revenues for Q2 Up 25%




Opthea Presents Additional Positive Data from OPT-302 Phase 1/2a Wet AMD Trial at ASRS Meeting

Tue, 15 Aug 2017 05:30:00 EDT

MELBOURNE, AUSTRALIA--(Marketwired - Aug 15, 2017) - Opthea Limited (ASX: OPT), a developer of novel biologic therapies for the treatment of eye diseases, today announced further positive results from its Phase 1/2a clinical trial of OPT-302, a novel VEGF-C/D 'Trap' therapy for wet age-related macular degeneration (wet AMD). 




Cannabis Wheaton Announces Appointment of New Advisory Board Member

Tue, 15 Aug 2017 00:01:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 15, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE:CBW) ("Cannabis Wheaton" or "CW") is pleased to announce the appointment of Elfi Daniel-Ivad to the Advisory Board of Cannabis Wheaton.




The Most Popular Phase of Product Development for Starting Medical Publications Activities

Mon, 14 Aug 2017 20:42:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - August 14, 2017) - A new study by business intelligence provider Cutting Edge Information found that the highest percentage of surveyed life science teams (30%) delay medical publications activities until products enter the registration and launch phase of product development.




Neptune annonce ses résultats pour le premier trimestre

Mon, 14 Aug 2017 17:31:13 EDT

Le produit de sa dernière transaction sera affecté à des acquisitions et à des projets de croissance

Trésorerie pro forma estimée à 35 millions de dollars




Acasti Pharma Reports First Quarter FY 2018 Financial Results

Mon, 14 Aug 2017 17:30:00 EDT

LAVAL, QUÉBEC--(Marketwired - Aug. 14, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced its operating and financial results for the quarter ended June 30, 2017, which is the first quarter of Acasti's fiscal year 2018. All amounts are in Canadian dollars.




Neptune Announces First Quarter Results

Mon, 14 Aug 2017 17:30:00 EDT

Proceeds from Recent Transaction to be Redeployed to Acquisitions and Growth Projects

Proforma cash estimated at $35 million




VistaGen Therapeutics Reports First Fiscal Quarter 2018 Financial Results and Provides Business Update

Mon, 14 Aug 2017 16:05:00 EDT

SOUTH SAN FRANCISCO, CA--(Marketwired - August 14, 2017) - VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, today reported its financial results for its first fiscal quarter ended June 30, 2017.




Agritek Holdings, Inc. Announces Phase One Construction On 25,000 Sq. Ft. Cultivation Facility In Puerto Rico

Mon, 14 Aug 2017 09:00:00 EDT

LOS ANGELES, CA--(Marketwired - Aug 14, 2017) - Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com, a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector today announced that phase one of construction will begin this month at the 1919 Clinic's 25,000 square foot cultivation and manufacturing facility located in San Juan, Puerto Rico. Agritek Holdings will provide funding for the build out of the operation, extraction and all equipment as well as cultivation experts under the Agritek team through its executed five (5) year Operations and Licensing Agreement with 1919 Clinic. The Operations and Licensing Agreement entitles Agritek to multiple revenue streams including monthly consulting fees, equipment lease back fees, as well as exclusivity for the sale of Agritek brands including vape products, oils and edibles upon meeting all the standards as set forth for legal operation by the Department of Health for Puerto Rico.




Cannabix: Capitalize on Pent-Up Demand for Cannabis Breathalyzer -- CFN Media

Mon, 14 Aug 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Aug 14, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) and its upcoming marijuana breathalyzer designed to help law enforcement detect the presence of tetrahydrocannabinol ("THC") at roadside and ultimately prosecute offenders. Without a reliable roadside breathalyzer, law enforcement officials are limited to pushing for invasive blood work or simply relying on public education programs to curb the problem. The good news is that Cannabix Technologies is rapidly developing a breathalyzer solution to address these concerns.




Knight Supports Crescita Trajectory

Mon, 14 Aug 2017 08:35:00 EDT

MONTREAL, QUEBEC--(Marketwired - Aug. 14, 2017) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has amended its secured loan agreement with Crescita Therapeutics Inc. (TSX:CTX) ("Crescita"), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products.




Knight appuie le parcours de Crescita

Mon, 14 Aug 2017 08:35:00 EDT

MONTRÉAL, QUÉBEC--(Marketwired - 14 août 2017) - Thérapeutique Knight inc. (TSX:GUD) («?Knight?»), société pharmaceutique spécialisée et chef de file au Canada, a annoncé aujourd'hui la modification de son entente de prêt garanti avec Crescita Therapeutics Inc. (TSX:CTX) («?Crescita?»), une société commerciale en dermatologie détentrice d'un portefeuille de produits de soins de la peau vendus sans ordonnance et de médicaments sur ordonnance.




Solis Tek, Inc. Announces Second Quarter 2017 Results

Mon, 14 Aug 2017 08:30:00 EDT

Introduction of Rare Nutrient Line for Terpene Enhancement to Fuel Growth Among Commercial Cannabis Growers




Cleveland BioLabs Reports Second Quarter 2017 Financial Results and Development Progress

Mon, 14 Aug 2017 08:12:09 EDT

BUFFALO, NY--(Marketwired - Aug 14, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2017.




Critical Outcome Technologies Completes Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies

Mon, 14 Aug 2017 08:00:00 EDT

- COTI-2 safe and well-tolerated at doses up to 1.7 mg/kg

- Company to advance into head and neck squamous cell carcinoma expansion arm




Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2017

Mon, 14 Aug 2017 07:30:00 EDT

HOUSTON, TX--(Marketwired - August 14, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center ("MD Anderson"), today announced its financial and operating results for the second quarter ended June 30, 2017 and other recent developments.




Cannabis Science 2017 Black Tie Gala Event Draws Near as Cannabis Science Completes Major Milestones and Operational Goals

Fri, 11 Aug 2017 14:36:42 EDT

IRVINE, CA--(Marketwired - Aug 11, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company has met most of our key strategic goals for 2017, and plans are well underway for the 2017 Cannabis Science Black Tie Gala. The Gala, scheduled for the 4th quarter of this year, will be an opportunity for Cannabis Science to demonstrate the Company's appreciation for its shareholders, and to present shareholders and stakeholders an overview of Cannabis Science's many upcoming and exciting initiatives. The venue for the Gala will be in the Beverly Hills/Hollywood area of Los Angeles, CA, and will be announced shortly.